293 related articles for article (PubMed ID: 30907497)
41. Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.
Desai PC; May RC; Jones SK; Strayhorn D; Caughey M; Hinderliter A; Ataga KI
Br J Haematol; 2013 Sep; 162(6):836-41. PubMed ID: 23829561
[TBL] [Abstract][Full Text] [Related]
42. Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension.
van Beers EJ; Nur E; Schaefer-Prokop CM; Mac Gillavry MR; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Muskiet FA; Schnog JJ; Biemond BJ;
Am J Hematol; 2008 Nov; 83(11):850-4. PubMed ID: 18819095
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary hypertension in well-transfused thalassemia major patients.
Meloni A; Detterich J; Pepe A; Harmatz P; Coates TD; Wood JC
Blood Cells Mol Dis; 2015 Feb; 54(2):189-94. PubMed ID: 25488617
[TBL] [Abstract][Full Text] [Related]
44. Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidence.
Shah P; Suriany S; Kato R; Bush AM; Chalacheva P; Veluswamy S; Denton CC; Russell K; Khaleel M; Forman HJ; Khoo MCK; Sposto R; Coates TD; Wood JC; Detterich J
Am J Hematol; 2021 Jan; 96(1):31-39. PubMed ID: 32944977
[TBL] [Abstract][Full Text] [Related]
45. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
46. Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
Heitzer AM; Longoria J; Okhomina V; Wang WC; Raches D; Potter B; Jacola LM; Porter J; Schreiber JE; King AA; Kang G; Hankins JS
Br J Haematol; 2021 Oct; 195(2):256-266. PubMed ID: 34272726
[TBL] [Abstract][Full Text] [Related]
47. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease.
Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA
Pediatr Pulmonol; 2009 Mar; 44(3):281-9. PubMed ID: 19205056
[TBL] [Abstract][Full Text] [Related]
48. Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought?
Hebson C; New T; Record E; Oster M; Ehrlich A; Border W; James-Herry A; Kanaan U
J Pediatr Hematol Oncol; 2015 Mar; 37(2):134-9. PubMed ID: 24942020
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary hypertension in sickle cell disease: relevance to children.
Kato GJ; Onyekwere OC; Gladwin MT
Pediatr Hematol Oncol; 2007; 24(3):159-70. PubMed ID: 17454785
[TBL] [Abstract][Full Text] [Related]
50. Haematological determinants of cardiac involvement in adults with sickle cell disease.
Damy T; Bodez D; Habibi A; Guellich A; Rappeneau S; Inamo J; Guendouz S; Gellen-Dautremer J; Pissard S; Loric S; Wagner-Ballon O; Godeau B; Adnot S; Dubois-Randé JL; Hittinger L; Galactéros F; Bartolucci P
Eur Heart J; 2016 Apr; 37(14):1158-1167. PubMed ID: 26516176
[TBL] [Abstract][Full Text] [Related]
51. Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.
Liem RI; Young LT; Lay AS; Pelligra SA; Labotka RJ; Thompson AA
Am J Hematol; 2010 Oct; 85(10):741-5. PubMed ID: 20652966
[TBL] [Abstract][Full Text] [Related]
52. Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country.
Lobo C; Moura P; Fidlarczyk D; Duran J; Barbosa R; Oliveira T; do Nascimento EM; Bhakta N; Hankins JS
BMC Health Serv Res; 2022 Jan; 22(1):42. PubMed ID: 34998394
[TBL] [Abstract][Full Text] [Related]
53. Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease.
van der Land V; Peters M; Biemond BJ; Heijboer H; Harteveld CL; Fijnvandraat K
Thromb Res; 2013; 132(6):712-7. PubMed ID: 24182550
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
[TBL] [Abstract][Full Text] [Related]
55. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.
Darbari DS; Onyekwere O; Nouraie M; Minniti CP; Luchtman-Jones L; Rana S; Sable C; Ensing G; Dham N; Campbell A; Arteta M; Gladwin MT; Castro O; Taylor JG; Kato GJ; Gordeuk V
J Pediatr; 2012 Feb; 160(2):286-90. PubMed ID: 21890147
[TBL] [Abstract][Full Text] [Related]
56. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
Pack-Mabien A; Brown B; Herbert DE; Haynes J
J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
[TBL] [Abstract][Full Text] [Related]
57. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.
Ilerhunmwuwa NP; Inyang L; Wasifuddin M; Aiwuyo H; Tahir M; Hakobyan N; Ankah P; Torere BE; Amaechi UM; Rayapureddy AK; Wang JC
Eur J Haematol; 2023 Oct; 111(4):611-619. PubMed ID: 37477175
[TBL] [Abstract][Full Text] [Related]
58. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
59. Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective, Double-blinded, Randomized Placebo-controlled Clinical Trial.
Onalo R; Cilliers A; Cooper P; Morris CR
Am J Respir Crit Care Med; 2022 Jul; 206(1):70-80. PubMed ID: 35426778
[No Abstract] [Full Text] [Related]
60. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
Machado RF; Barst RJ; Yovetich NA; Hassell KL; Kato GJ; Gordeuk VR; Gibbs JS; Little JA; Schraufnagel DE; Krishnamurti L; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Onyekwere O; Castro OL; Sachdev V; Waclawiw MA; Woolson R; Goldsmith JC; Gladwin MT;
Blood; 2011 Jul; 118(4):855-64. PubMed ID: 21527519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
